INVESTOR ALERT: Hagens Berman Investigates Hedge Fund

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
INVESTOR ALERT: Hagens Berman Investigates Hedge Fund Platinum Partners LP and its Value Arbitrage and Credit Opportunities Funds

SAN FRANCISCO, July 28, 2016 (GLOBE NEWSWIRE) -- Hagens Berman Sobol Shapiro LLP has initiated investigation of Platinum Partners LP and its flagship hedge funds, the Platinum Partners Value Arbitrage Fund and the Platinum Partners Credit Opportunities Fund, for potentially defrauding investors .

If you are invested with Platinum Partners LP hedge funds, contact Hagens Berman Sobol Shapiro LLP through our website at:

https://www.hbsslaw.com/cases/Platinum

or contact Reed Kathrein, who is leading the firm’s investigation, by calling 510-725-3000 or emailing Platinum@hbsslaw.com .

The Firm’s investigation is focused on whether Platinum Partners paid investors who redeemed their hedge fund positions before June 2016 with money gained from newly incoming investors – the hallmarks of a Ponzi scheme. Hagens Berman is also investigating whether Platinum misstated the value  of its investments, for which there was no public market price, and whether Platinum Partners executives, including Murray Huberfeld, Mark Nordlicht, and others, may have assisted in any wrongdoing that caused harm to Platinum investors.

After posting some of the most impressive investment returns in the industry, Platinum Partners announced liquidation of its two hedge funds in a July 20, 2016 letter to investors. Platinum Partners has apparently also suspended any redemption by investors.

In June, the press reported that the Securities and Exchange Commission and the Department of Justice are both investigating Platinum Partners for bribery and fraud. The Federal Bureau of Investigation raided Platinum Partners offices, and Platinum Partners’ manager, Murray Huberfield, was arrested for bribing union officials to invest in Platinum’s funds.

“Hagens Berman has extensive experience representing investors in litigation involving Ponzi schemes like the Madoff Ponzi scheme,” said Hagens Berman partner Reed Kathrein. “We can only hope that this situation is not similar to the Madoff scheme, where we had to go after banks, auditors and other third-parties who either turned a blind eye to any wrongful conduct or aided and abetted.”

Whistleblowers: Persons with non-public information regarding Platinum Partners should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new SEC whistleblower program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 510-725-3000 or email Platinum@hbsslaw.com .

About Hagens Berman Hagens Berman is a national investor-rights law firm headquartered in Seattle, Washington with offices in 10 cities. The Firm represents investors, whistleblowers, workers and consumers in complex litigation. More about the Firm and its successes can be found at www.hbsslaw.com . Read the Firm’s Securities Newsletter , and visit the blog . For the latest news visit our newsroom or follow us on Twitter at @classactionlaw .

Contact: Reed Kathrein, 510-725-3000

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Employment Law Suit Hits ABC: Alleged Wage Violations

Updated Category News Views 160

ABC Under Fire for Labor Code Violations You know it's a rocky road when a company like American Broadcasting Companies, Inc. lands itself in hot water with accusations riding high on labor law violations. People yapping about lunch breaks? Well, that’s the ball game here. Meal and Rest Break Controversies According to a recent lawsuit filed by Blumenthal Nordrehaug...

Continue Reading
Championing Change: USTA Mid-Atlantic Gala's Impact

Updated Category News Views 297

A Night to Remember: USTA Mid-Atlantic's Gala Who would've thought tennis could wield such transformative power? This ain't your average sport gala. Last Saturday, a crowd of over 300 gathered at the Ritz-Carlton Tysons Corner for the USTA Mid-Atlantic Foundation's 2026 Tennis Creates Gala. Hosted by the formidable Malika Andrews, this event wasn't just a fancy...

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 258

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading
KINGRVER Boosts RV Comfort with New Water Heater Lineup

Updated Category News Views 308

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 115

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 266

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 304

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
Innovent's Big Leap: Targeting European Lung Cancer Market

Updated Category News Views 85

Innovent's Regulatory Milestone in Europe They say every underdog has its day, and for Innovent Biologics, that time just might be now. Receiving a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) is no small potatoes. Especially when we're talking lung cancer—a notorious heavyweight in the cancer world. The Finer Details of Zybrivo’s...

Continue Reading
Thunes Boosts Bhutan Remittances with Instant Payments

Updated Category News Views 85

Thunes' Network Expands to Bhutan: A Game Changer I'll say one thing clear—Thunes isn't messing around. They've just opened the gates for real-time payouts to Bhutan, and it's going to be a game-changer for those living abroad who want to send money back home. Look, for years, Non-Resident Bhutanese have been diving into hoops just to get their bucks across borders....

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 225

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading

Top 5 Most Recently Viewed Articles

Innovative DREAM JEANS Enhance Natural Curves with Comfort

Updated Category News Views 194

Stylish Jeans for a Natural Lift In the world of fashion, innovation often leads to surprising breakthroughs that combine style with functionality. One exciting development comes from an inventor who has created a brand-new jean design aimed at enhancing the natural shape of the body. The DREAM JEANS are crafted to provide lift, contour, and shape to the derriere,...

Continue Reading
Swvl Introduces New Contracts and Expands in Saudi Arabia

Updated Category News Views 113

Swvl's New Contracts Signal Growth in Saudi Arabia Swvl Holdings Corp, a leading provider of technology solutions for enterprise and government mobility, has recently made news by finalizing new contracts in Saudi Arabia. These agreements add a remarkable $2.6 million to the company's annual contract value, which accounts for approximately ten percent of Swvl's total...

Continue Reading
Arizona Sonoran Implements New Shareholder Rights Plan

Updated Category News Views 202

Arizona Sonoran Copper Company Announces New Rights Plan Arizona Sonoran Copper Company Inc. (TSX:ASCU | OTCQX:ASCUF) has taken an important step for its shareholders by adopting a new shareholder rights plan effective as of a date in the future. This move is intended to ensure that all shareholders are treated equitably in any future takeover attempts and to guard...

Continue Reading
Champ the Golden Retriever: First Live Mascot of 2026 Games

Updated Category News Views 243

Meet Champ: The Inspiring Live Mascot of the 2026 USA Games As the world prepares for the 2026 Special Olympics USA Games, there's an exciting new addition to the team - Champ, a golden retriever therapy dog. Champ is set to be the first-ever live mascot in the history of these games, embracing the role with an important mission beyond just being a charming face. She is...

Continue Reading
Investors Alert: Important Update on BioAge Labs Safety Issues

Updated Category News Views 147

A Deep Dive into the BioAge Labs Situation Faruqi & Faruqi, LLP is actively assisting investors from BioAge Labs, Inc. (NASDAQ: BIOA) who have experienced losses exceeding $75,000. If you are one of these investors, it is vital to reach out and explore your legal options. Understanding Your Rights Investors who encountered significant losses between critical periods...

Continue Reading